Minimal clinically important improvement response in patients with severe osteoarthritis of the knee: Short report from a survey of clinicians.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 29881169.
- Also identified by DOI 10.1016/j.jor.2018.03.034 and PMC identifier 5990343.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The minimal clinically important improvement (MCII) is the smallest change that signifies an important improvement. Disease severity may complicate MCII. We developed an eight-question survey examining MCII in patients with severe knee osteoarthritis (Kellgren-Lawrence grade 4). Twenty-seven of 101 clinicians completed the survey. An MCII of 20% was selected most frequently for pain, function, and patient global assessment. Clinicians were divided on responder rate, selecting 20%, 30%, and 50% equally. These findings suggest a 20% MCII may be useful in patients with severe osteoarthritis, but that there is not enough evidence to support a responder rate in this population.
Anatomy
- knee